Not much to add. Dog tolerates it and price is good

Bravecto Quantum for dogs is a long-acting prescription injection used to treat and prevent flea infestations and control several tick species. It is administered under the skin by a licensed veterinarian and is approved in the United States for dogs and puppies 6 months of age and older.
One injection can provide 12 months of control against fleas and five labeled tick species. However, control of lone star ticks lasts only 8 months. This distinction is important when your veterinarian determines when your dog’s next injection is due.
Although long-lasting parasite control can be convenient, this treatment is not automatically the best option for every dog. Your veterinarian should consider your dog’s age, weight, medical history, neurologic health, previous medication reactions, lifestyle, and likely exposure to different tick species.
Bravecto Quantum is an extended-release injectable flea and tick medication containing fluralaner. Fluralaner belongs to the isoxazoline class of antiparasitic drugs.
Unlike oral chews or topical treatments given at home, Bravecto Quantum for dogs must be prescribed and administered at a veterinary clinic. It is injected beneath the skin near the shoulder blade area.
The medication is not a vaccine. Instead, fluralaner is gradually released into the dog’s body, where it remains active against susceptible fleas and ticks for an extended period.
Bravecto Quantum was first approved in the United States in July 2025 as the first FDA-approved flea and tick treatment offering 8–12 months of control with a single veterinary-administered dose. Its U.S. indications were expanded in March 2026 to include Asian longhorned and Gulf Coast ticks for 12 months.
The current U.S. label separates parasite coverage according to species.
|
Parasite |
Labeled duration |
|
Adult fleas |
12 months |
|
12 months |
|
|
12 months |
|
|
12 months |
|
|
Asian longhorned ticks |
12 months |
|
Gulf Coast ticks |
12 months |
|
8 months |
Bravecto Quantum for dogs kills adult fleas and is indicated for the treatment and prevention of flea infestations for 12 months.
It also treats and controls infestations involving black-legged, American dog, brown dog, Asian longhorned, and Gulf Coast ticks for 12 months.
The lone star tick is the main exception. The product treats and controls lone star tick infestations for 8 months and is not considered effective against this species beyond that period. Dogs that may encounter lone star ticks should generally follow an 8-month treatment schedule rather than an annual schedule.
Your veterinarian can assess which tick species are common where your dog lives, walks, hikes, boards, or travels.
Bravecto Quantum for dogs is specifically intended for fleas and the tick species included on its label.
It is not labeled to prevent or treat:
Your dog may still need separate heartworm prevention and intestinal parasite control. A veterinarian can create a complete parasite-prevention plan based on your dog’s lifestyle and local risks.
Fluralaner affects specific chloride channels in the nervous systems of fleas and ticks. Disruption of these channels interferes with normal nerve activity, eventually killing susceptible parasites.
Because the medication works systemically, fleas and ticks generally need to feed on the dog before the dog is exposed to fluralaner. This means the product should not be described as a treatment that prevents every tick from attaching.
Bravecto Quantum for dogs is formulated to release fluralaner gradually. This extended-release action allows one injection to remain effective for much longer than monthly flea and tick treatments.
You may still occasionally find a tick on a treated dog, particularly shortly after the injection or after visiting a heavily infested area. Continue checking your dog after outdoor activities and promptly remove any attached ticks.
Bravecto Quantum must be prepared and administered by a licensed veterinarian. Pet owners should never attempt to mix or inject the medication at home.
The veterinarian will weigh your dog at the appointment and calculate an accurate dose based on current body weight.
The approved dose is:
The medication is given as a single subcutaneous injection in the dorsoscapular region, the upper back area around the shoulder blades. It is intended only for subcutaneous administration and should not be given by another route.
For fleas and the five tick species with 12-month coverage, Bravecto Quantum for dogs is generally administered once every 12 months. When there is potential exposure to lone star ticks, the recommended interval is every 8 months.
Bravecto Quantum does not necessarily eliminate every visible parasite immediately.
In controlled studies, it was 100% effective against existing adult flea infestations within 48 hours after treatment. It also maintained at least 99.7% effectiveness against later adult flea infestations when assessed 24 hours after exposure from approximately one week through 12 months.
The onset of tick control varied by species. For ticks already present at the time of treatment, the official prescribing information reports that the required effectiveness level was reached:
It may therefore take approximately 3–5 days to notice a meaningful reduction in ticks already present on the dog.
Finding a tick soon after treatment does not necessarily mean the medication has failed. Remove visible ticks correctly and contact your veterinarian if the infestation remains heavy or appears to worsen.
Like all medications, Bravecto Quantum for dogs can cause side effects. Many dogs tolerate treatment without serious problems, but owners should know what to monitor after the injection.
During a U.S. field study involving 225 treated dogs, the following potential adverse reactions were recorded:
Lethargy
Decreased appetite
Vomiting
Diarrhea
Itching
Seizures
Contact your veterinarian if your dog develops persistent tiredness, reduced appetite, repeated vomiting, ongoing diarrhea, significant itching, unusual behavior, or swelling after treatment.
Bravecto Quantum contains an isoxazoline-class medication. Drugs in this class have been associated with neurologic reactions, including:
Neurologic reactions have been reported in some dogs without a history of seizures. Bravecto Quantum for dogs should therefore be used cautiously in dogs with a history of seizures or other neurologic disorders.
Before treatment, tell your veterinarian if your dog has ever experienced:
A history of seizures does not necessarily mean a dog can never receive an isoxazoline medication. However, the veterinarian should evaluate the potential benefits, risks, and available alternatives.
Seek urgent veterinary care if your dog develops a seizure, repeated tremors, severe disorientation, loss of balance, collapse, or difficulty standing after the injection.
Hypersensitivity reactions, including anaphylaxis, have been reported after Bravecto Quantum administration.
In the U.S. field study, one treated dog developed hives, facial swelling, vomiting, and heavy breathing within 12 hours of receiving the first injection. The dog was treated and recovered within 24 hours.
Possible signs of a serious allergic reaction include:
These symptoms require immediate veterinary attention. Do not wait to see whether breathing difficulty, facial swelling, or collapse improves without treatment.
A small lump, bump, or area of swelling may develop at the injection site.
Mild injection-site reactions were reported in three dogs during the U.S. field study. The reactions resolved 1, 4, and 27 days after they were first observed.
Contact the veterinary clinic if the injection site:
Do not massage the injection site or apply creams, medication, ice, or heat unless your veterinarian recommends doing so.
The official U.S. label lists no known contraindications. However, this does not mean that Bravecto Quantum for dogs is suitable for every animal.
A careful veterinary assessment is particularly important for dogs that:
Because Bravecto Quantum is a long-acting injection, it cannot simply be removed or discontinued after administration. Discussing your dog’s complete medical history before treatment is especially important.
Bravecto Quantum is approved for puppies that are at least 6 months old.
Its safety and effectiveness have not been evaluated in dogs younger than 6 months. Younger puppies need a flea and tick treatment specifically approved for their age, weight, and health status.
Never divide another dog’s medication, use an adult product on a young puppy, or combine parasite treatments without veterinary guidance.
The safety of Bravecto Quantum for dogs has not been evaluated in:
The prescribing information also notes that reproductive adverse events have been reported following the use of Bravecto Chews in breeding females. Reported events included birth defects, stillbirth, and abortion.
Those reports involved the oral chewable formulation and do not establish that the injectable product caused the same outcomes. However, breeding, pregnancy, and nursing status should be discussed with the veterinarian before treatment.
In the U.S. field study, Bravecto Quantum was used alongside several common types of veterinary treatments, including:
No adverse reactions attributed to the concurrent use of these treatments were observed during that study. However, this does not confirm that every possible combination of drugs or supplements is safe.
Give your veterinarian a complete list of everything your dog receives, including prescription medications, supplements, herbal products, heartworm preventives, and other flea or tick treatments.
Do not combine parasite-control products unless a veterinarian has confirmed that the combination is appropriate.
Many dogs return to their normal routines following the injection. Nevertheless, monitor your dog carefully, especially during the first several days.
Watch for:
Mild symptoms that persist, recur, or become worse should be reported to your veterinarian.
Breathing difficulty, collapse, facial swelling, seizures, or severe loss of coordination require emergency veterinary care.
Record the treatment date and the recommended next appointment. Depending on your dog’s tick exposure, the next injection may be due in 8 months rather than 12 months.
Long-lasting treatment may be convenient for owners who struggle to remember monthly parasite prevention or whose dogs refuse chewable medications.
Possible benefits include:
Bravecto Quantum for dogs may also be helpful for households in which applying topical medication is difficult.
However, convenience should not be the only consideration. Your dog’s health, neurologic history, local parasite risks, and previous reactions should guide the final decision.
No single flea and tick treatment is best for every dog.
Bravecto Quantum may be considered when:
A shorter-acting chew or topical treatment may be preferred when:
Your veterinarian can help compare the benefits and risks of each option.
Before choosing Bravecto Quantum for dogs, remember that:
Always follow the prescribing information and veterinary guidance applicable where your dog receives treatment.
It provides 12 months of treatment and prevention for flea infestations and 12 months of control against black-legged, American dog, brown dog, Asian longhorned, and Gulf Coast ticks.
Control against lone star ticks lasts only 8 months.
It may be given every 12 months when the dog’s parasite risk involves fleas and the five tick species covered for a full year.
When exposure to lone star ticks is possible, Bravecto Quantum for dogs should generally be administered every 8 months.
No. Bravecto Quantum must be prepared, prescribed, and administered by a licensed veterinarian.
No. It is an extended-release antiparasitic medication containing fluralaner.
Isoxazoline medications have been associated with tremors, poor coordination, and seizures. The product should be used with caution in dogs with a history of seizures or neurologic disease.
Your veterinarian must evaluate the individual dog’s risks and available alternatives.
No. It is not a heartworm preventive. Your dog may require a separate medication for heartworm and intestinal parasite protection.
It may take approximately 3–5 days to notice a substantial reduction in ticks already present. The speed of control also differs between tick species.
Continue inspecting your dog and safely remove any attached ticks.
No. The injectable product discussed in this article is approved only for dogs and puppies at least 6 months old.
Because the medication is injected under the skin rather than applied to the coat, bathing does not wash it away. Follow your veterinarian’s instructions, especially if the injection site is irritated or swollen.
Bravecto Quantum for dogs provides a convenient, long-lasting alternative to frequently administered flea and tick treatments. One veterinary injection can treat and prevent flea infestations and control five labeled tick species for 12 months.
Lone star ticks are the important exception. Control against this species lasts only 8 months, making an 8-month treatment schedule necessary when exposure is possible.
Before choosing this medication, discuss your dog’s age, health history, seizure risk, breeding status, current medications, travel plans, and local parasite exposure with your veterinarian.
When prescribed appropriately and combined with heartworm prevention, intestinal parasite control, environmental management, and regular tick checks, Bravecto Quantum can form part of a comprehensive year-round parasite-control plan.
Medical Disclaimer: This article is intended for general educational purposes only and does not replace veterinary examination, diagnosis, prescribing, or treatment. Always consult a licensed veterinarian before starting, changing, combining, or discontinuing any parasite medication.